ACE2 and COVID-19: Prescribing drugs that may affect ACE2, such as ACEI, ARB, or ACE2 activators and targeting ACE2 by using hrsACE2 can be a potential therapeutic strategy for COVID-19; however, more clinical studies are needed to confirm the effectiveness of these methods.